What Jenna Fischer's Story Can Teach Us About Breast Cancer and Dense Breasts

What Jenna Fischer shared

On October 8, 2024, the actor Jenna Fischer posted that she had been diagnosed with stage 1 triple-positive breast cancer in December 2023, and that after surgery, chemotherapy and radiation she was cancer-free.

The sequence she described is the useful part. In October 2023 she went for a routine mammogram she had been putting off. Three weeks later her doctor called. "Your mammogram was fine," Fischer recalled being told. "There were a few spots that were difficult to see. You have very dense tissue. We would recommend that you do another mammogram and maybe follow up with a breast ultrasound."

She had the ultrasound with no real worry. Then came a request for a biopsy, with what she was told was roughly a 10 percent chance of cancer. She read the result on a patient portal while out on a hike: "invasive," "ductal," "carcinoma," "malignant."

She had a lumpectomy in January 2024, then 12 weeks of chemotherapy and three weeks of radiation, and she said she remained on Herceptin infusions and daily tamoxifen. She waited a year to go public, she said, so she could urge people to keep their mammogram appointments. "If I had waited six months longer, things could have been much worse."

That is her account. Her further care is her business, and this page will not speculate about it.

Dense breasts, explained

Breast density is not something you can feel, and it is not something a doctor can find on an exam. Only a radiologist reading a mammogram can tell. It describes how much glandular and fibrous tissue a breast has, relative to fat.

Radiologists sort density into four categories using a system called BI-RADS. About 10 percent of women are almost entirely fatty. About 40 percent have scattered fibroglandular tissue. About 40 percent are heterogeneously dense. About 10 percent are extremely dense. The last two count as "dense," and that covers nearly half of all women aged 40 and over who get mammograms.

Density matters for two separate reasons, and they are easy to confuse.

Why density makes a mammogram harder to read

On a mammogram, fat looks dark. Dense tissue looks white. So do calcifications and tumors. A cancer in dense tissue is a white thing sitting in front of a white background.

NCI states the consequence plainly: mammography is less sensitive in women with dense breasts, meaning it is more likely to miss cancer. Women with dense breasts also get called back for extra tests more often. That is exactly what happened to Fischer, and it is why the ultrasound was ordered.

The second reason is separate: dense breasts are themselves a risk factor. Women with dense breasts have a higher risk of breast cancer than women with fatty breasts, independent of the reading problem.

One reassurance is worth stating alongside that. NCI reports that women with dense breasts who develop breast cancer are no more likely to die from it than women with fatty breasts, after accounting for other health factors and tumor characteristics.

What the guidelines actually say about extra imaging

Updated FDA rules require mammography providers to tell women whether they have dense breasts. Knowing is now the default.

What to do next is less settled. The US Preventive Services Task Force concludes that current evidence is insufficient to assess the balance of benefits and harms of supplemental ultrasound or MRI in women found to have dense breasts on an otherwise negative mammogram. NCI says the same. That is not a recommendation against extra imaging. It is an honest statement that the evidence has not settled the question, which makes it a conversation to have rather than a rule to follow. Our page on breast density covers what to ask.

For routine screening itself, the Task Force recommends mammography every two years for women aged 40 to 74. Our guide to mammograms explains what the appointment involves.

When to get checked

• Keep the routine mammogram, and keep the follow-up appointment if one is ordered. The follow-up is what found Fischer's cancer.
• A new lump or thickening in the breast or armpit that lasts through a menstrual cycle.
• A change in the shape or size of one breast, or skin that dimples, puckers or thickens.
• A nipple that turns inward, or new nipple discharge, especially if bloody or from one side.
• Skin that is red, scaly or warm over part of the breast.
• Do not wait for the next scheduled screening if you notice any of these. Symptoms need their own workup.

What "triple-positive" means

After a biopsy, the laboratory tests the tumor for three markers: the estrogen receptor, the progesterone receptor and a protein called HER2. Those three results split breast cancer into groups that behave differently and respond to different drugs.

Triple-positive means all three are present. Hormone receptors mean the cancer can be treated with drugs that block estrogen, such as tamoxifen. HER2-positive means HER2-directed drugs such as trastuzumab, sold as Herceptin, are an option. Triple-negative means none of the three, and a different plan.

Fischer's own description tracks that logic: an aggressive subtype, but one with several treatment routes available. Invasive ductal carcinoma, the type named in her pathology report, means the cancer began in a milk duct and grew into surrounding breast tissue.

The survival picture

The American Cancer Society projects 321,910 new female breast cancers in the United States in 2026 and 42,140 deaths, figures SEER, the federal cancer statistics program, reprints. SEER's own staging records show about 64 percent are found while still confined to the breast, 27 percent have reached nearby lymph nodes and 6 percent have spread further.

Five-year relative survival across all stages was 91.9 percent for women diagnosed from 2016 through 2022. Death rates are falling. Around 4.2 million American women were living with a breast cancer diagnosis in 2023.

Those are group numbers about people diagnosed years ago. They describe a population, not a person, and they cannot tell any individual what to expect.

What this does not mean

Dense breasts are not a disease and not an abnormal finding. Nearly half of women screened have them.

An inconclusive mammogram is also not bad news. It is usually the system working: a reader flagged something hard to see and asked for a better look. Most callbacks end in nothing. Our overview of breast cancer sets out the types and stages in full.

Sources

• https://www.goodmorningamerica.com/culture/story/jenna-fischer-says-she-is-cancerfree-after-breast-cancer-114617317
• https://www.nbcnews.com/health/cancer/jenna-fischer-breast-cancer-interview-rcna176370
• https://www.cancer.gov/types/breast/breast-changes/dense-breasts
• https://www.cancer.gov/types/breast/hp/breast-treatment-pdq
• https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
• https://seer.cancer.gov/statfacts/html/breast.html

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.